Bausch Health Companies Inc. (BHC) Next Earnings Date & Options-Implied ±6.8% Move
Bausch Health Companies Inc. (BHC) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (62/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+232.3% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Options-Implied Post-Earnings ±6.8% Bell Curve
Will BHC Beat & Rip or Miss Next Quarter?
Trailing EPS: $0.42 • YoY Revenue Growth: 6.7%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $10.27B | $157.0M | $1.00B | 44% |
| FY 2024 | 2024-12-31 | $9.63B | -$46.0M | $1.26B | 44% |
| FY 2023 | 2023-12-31 | $8.76B | -$592.0M | $637.9M | 44% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring BHC)
- ✓Live walkthrough of BHC's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
BHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BHC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BHC. Explore sector supply chains on /butterfly.
BHC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is BHC's next earnings date?
Based on SEC filing cadence, Bausch Health Companies Inc. (BHC)'s next quarterly earnings window is estimated around Dec 30, 2026.
How much is BHC stock expected to move on earnings?
Options markets currently imply a ±6.8% post-earnings move for BHC, projecting a trading range between $8.3 and $9.52.